Immuron

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immuron and other ETFs, options, and stocks.

About IMRN

Immuron Ltd. engages in the research and development of oral immunotherapy, which focuses on bovine-colostrum with antibodies of choice for the treatment and prevention of a range of infectious and immune modulated diseases. It operates through the Research and Development, and Hyperimmune Products segments.

CEO

Steven Lydeamore

CEOSteven Lydeamore

Employees

—

Employees—

Headquarters

Carlton, Victoria (VIC)

HeadquartersCarlton, Victoria (VIC)

Founded

1994

Founded1994

Employees

—

Employees—

IMRN Key Statistics

Market cap

14.14M

Market cap14.14M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

3.33K

Average volume3.33K

High today

$2.24

High today$2.24

Low today

$2.15

Low today$2.15

Open price

$2.24

Open price$2.24

Volume

1.71K

Volume1.71K

52 Week high

$4.40

52 Week high$4.40

52 Week low

$1.69

52 Week low$1.69

IMRN Earnings

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Estimated

— per share

Estimated— per share

Actual

Expected Sep 1, Pre-Market

ActualExpected Sep 1, Pre-Market